Site icon OncologyTube

Immune-Targeted Therapy in Breast Cancer Immune System Important for Long-Term Outcome

Sara A Hurvitz, MD, FACP Associate Professor of Medicine Director, Breast Oncology, examines Immune-Targeted Therapy in Breast Cancer Immune System Important for Long-Term Outcome. at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information

Advertisement
Exit mobile version